Similarly, the anti-MERTK monoclonal antibody Mer590 reduced surface MERTK protein levels by 87% and increased chemosensitivity and reduced colony formation in NSCLC cell lines [66]. This evidence concerns the gene MERTK and non-small cell lung carcinoma.